Biotech News

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Outset Medical (OM)Outset MedicalCompany update

SAN JOSE, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity (the “Company”), today announced that the Compensation Committee of

Related news

Outset Medical

Dialysis Technology Outset Medical develops technology intended to simplify dialysis delivery across hospitals, clinics and home-care settings. Tablo Hemodialysis System Tablo is an integrated hemodialysis system that combines water purification, on-demand dialysate production and treatment delivery in a single device. Its design seeks...

Recent company news

Stock data

Close
5.20 USD
Market cap
93.98M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States